Literature DB >> 22552833

Retrograde, transsubclavian implantation of a SAPIEN XT™ aortic valve prosthesis with the Edwards NovaFlex+™ system.

J Blumenstein, A Van Linden, J Kempfert, Woung-Keung Kim, C Liebetrau, C Hamm, H Nef, T Walther, H Moellmann.   

Abstract

Mesh：

Year:  2012        PMID： 22552833     DOI： 10.1007/s00392-012-0460-2

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  8 in total

1.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.

Authors:  Martin B Leon; Craig R Smith; Michael Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; David L Brown; Peter C Block; Robert A Guyton; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Pamela S Douglas; John L Petersen; Jodi J Akin; William N Anderson; Duolao Wang; Stuart Pocock
Journal:  N Engl J Med       Date:  2010-09-22       Impact factor: 91.245

Review 2.  Transcatheter aortic valve implantation: evidence on safety and efficacy compared with medical therapy. A systematic review of current literature.

Authors:  L Figulla; A Neumann; H R Figulla; P Kahlert; R Erbel; T Neumann
Journal:  Clin Res Cardiol       Date:  2010-12-17       Impact factor: 5.460

3.  First trans-axillary implantation of Edwards Sapien valve to treat an incompetent aortic bioprosthesis.

Authors:  Andrew S P Sharp; Iassen Michev; Antonio Colombo
Journal:  Catheter Cardiovasc Interv       Date:  2010-03-01       Impact factor: 2.692

4.  Transcutaneous aortic valve implantation using the axillary/subclavian access: feasibility and early clinical outcomes.

Authors:  Thomas Modine; Jean François Obadia; Emmanuel Choukroun; Gilles Rioufoul; Arnaud Sudre; Jean Claude Laborde; Pascal Leprince
Journal:  J Thorac Cardiovasc Surg       Date:  2011-02       Impact factor: 5.209

5.  One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.

Authors:  Martyn Thomas; Gerhard Schymik; Thomas Walther; Dominique Himbert; Thierry Lefèvre; Hendrik Treede; Holger Eggebrecht; Paolo Rubino; Antonio Colombo; Rüdiger Lange; Rebecca R Schwarz; Olaf Wendler
Journal:  Circulation       Date:  2011-07-11       Impact factor: 29.690

6.  Transcatheter aortic valve implantation transapical: step by step.

Authors:  Thomas Walther; Helge Möllmann; Arnaud van Linden; Jörg Kempfert
Journal:  Semin Thorac Cardiovasc Surg       Date:  2011

7.  Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system.

Authors:  Anna Sonia Petronio; Marco De Carlo; Francesco Bedogni; Antonio Marzocchi; Silvio Klugmann; Francesco Maisano; Angelo Ramondo; Gian Paolo Ussia; Federica Ettori; Arnaldo Poli; Nedy Brambilla; Francesco Saia; Federico De Marco; Antonio Colombo
Journal:  Circ Cardiovasc Interv       Date:  2010-07-06       Impact factor: 6.546

8.  The risk-to-benefit ratio of transcatheter aortic valve implantation in specific patient cohorts: a single-centre experience.

Authors:  Miriam Puls; Tanja Viel; Bernhard C Danner; Claudius Jacobshagen; Nils Teucher; Gunnar Hanekop; Friedrich Schöndube; Gerd Hasenfuss; Ralf G Seipelt; Wolfgang Schillinger
Journal:  Clin Res Cardiol       Date:  2012-02-21       Impact factor: 5.460
  8 in total
  2 in total

1.  Feasibility of sheathless transfemoral aortic valve implantation in patients with small access vessel diameters.

Authors:  Nicolas A Geis; Emmanuel Chorianopoulos; Klaus Kallenbach; Florian André; Sven T Pleger; Matthias Karck; Hugo A Katus; Raffi Bekeredjian
Journal:  Clin Res Cardiol       Date:  2014-04-21       Impact factor: 5.460

Review 2.  Worldwide TAVI registries: what have we learned?

Authors:  Stephan Haussig; Gerhard Schuler; Axel Linke
Journal:  Clin Res Cardiol       Date:  2014-03-20       Impact factor: 5.460
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.